News and Events
The pharmaceutical world is constantly evolving so it is paramount to stay up-to-date. Keep abreast of all Quinta’s announcements, insights and activities, as well as wider industry news right here.
16 December 2024
Welcome, 2025!
Reflecting on 2024 with gratitude and looking ahead with optimism.
2 December 2024
A Decade of Partnership with Adamed Pharma
Adamed Pharma and Quinta-Analytica’s 10 – Year Journey in Pharma Innovation
25 November 2024
Expediting Biosimilar development: Streamlining the path from research to market
On behalf of the Conscio Group, we would like to invite you to a free webinar on the future of the biosimilar pathway to approval, which is now open for registration.
18 September 2024
Determination of total bound iron in human blood serum samples
Ironing out the challenges: measuring total bound iron in blood serum in Ferric Carboxymaltose (FCM) Studies
4 September 2024
Meet us at the heart of Pharma at CPHI 2024
As a part of Conscio Group, we are attending CPHI 2024 in Milan, Italy.
18 March 2024
News from our newly opened clinic in Ostrava
Our new Clinic in Ostrava (CZ) is gaining momentum step by step; therefore, we have some interesting news for you from the center of the action.
19 December 2023
Happy new year 2024
As we bid farewell to 2023, it's time to express our deepest gratitude for the collaboration.
4 December 2023
Our new clinical unit in Ostrava comes to life
It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava with 36-beds capacity has been opened.
3 October 2023
Meet us at the heart of Pharma, CPHI 2023
Quinta-Analytica is attending CPHI 2023 in Barcelona
18 July 2023
Challenges of a large-scale study of breast cancer
Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.
29 June 2023
EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.
After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.
22 June 2023
Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies
EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency
15 June 2023
Novavax & Conscio: Behind the Scenes of Vaccine Development
Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.
8 June 2023
Ekolab And Conscio Group Join Forces
Ekolab joins the Conscio Group, enhancing our analytical capabilities and solidifying our position in pharmaceutical, nutrition, and technology solutions.
8 June 2023
Clinical Tips – Drug Interactions in Advanced Clinical Trial Design
Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.
6 April 2023
Transdermal Patches, Films and Topicals – Putting the Skin in the Game
Today we talk about novel drug delivery systems and in vitro testing techniques. Learn about our work with transdermal patches, orally dissolving films, topical products and Franz cell testing.
23 March 2023
Clinical Tips – Benefits of Sequential Designs in Bioequivalence Studies
Discover the power of sequential designs for bioequivalence studies, a crucial step in generics development: Their practical implementation, statistical analysis, and the well-being of the volunteers.
23 March 2023
A Prescription Against EU Medicine Shortages – Outsourcing Stabilities
We highlight the reasons behind current EU drug shortages and the key role CROs and outsourced stability testing play in diversifying drug production.
27 January 2023
Pharmaceutical Offshore Outsourcing in the USA: Opportunities & Misconceptions
Dr. Jeffrey Kiel, founder and CEO of Kiel Laboratories, talks about offshore outsourcing in the USA and working with Quinta-Analytica.
5 January 2023
From Houston to Munich – Innovation & Compounding
Pharma innovators often outsource demanding projects to specialist CROs. Gus Bassani of US-based PCCA and Markus Dachtler of Conscio's German subsidiary Gen-Plus, share lessons from their collaboration.
